Impaired cell functions of hepatocytes incubated with plasma of septic patients

Objective and design The development of liver failure is a major problem in septic patients. In this prospective clinical experimental study the hepatotoxicity of plasma from septic and non-septic patients was tested. Methods and subjects The basic test components consist of human liver cells (HepG2...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Inflammation research 2012-06, Vol.61 (6), p.609-616
Hauptverfasser: Sauer, Martin, Haubner, Cristof, Mencke, Thomas, Nöldge-Schomburg, Gabriele, Mitzner, Steffen, Altrichter, Jens, Stange, Jan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 616
container_issue 6
container_start_page 609
container_title Inflammation research
container_volume 61
creator Sauer, Martin
Haubner, Cristof
Mencke, Thomas
Nöldge-Schomburg, Gabriele
Mitzner, Steffen
Altrichter, Jens
Stange, Jan
description Objective and design The development of liver failure is a major problem in septic patients. In this prospective clinical experimental study the hepatotoxicity of plasma from septic and non-septic patients was tested. Methods and subjects The basic test components consist of human liver cells (HepG2/C3A) used in a standardized microtiter plate assay. After incubation with patient’s plasma viability of cells (XTT-test), the cytochrome 1A2 activity and synthesis of micro albumin were measured. Subjects (28) enrolled comprise the septic shock group (SSG, n  = 10), the non-septic group (NSG, n  = 5) and the healthy volunteers group (HVG, n  = 13). Results The 28-day mortality was 30% in the SSG. The APACHE II-, SOFA-, and SAPS-scores and the values of bilirubin and prothrombin time as INR were significantly higher in the SSG than in the NSG. The cytochrome 1A2 activity and the release of albumin were significantly reduced in HepG2/C3A cells incubated with plasma of the SSG ( p  
doi_str_mv 10.1007/s00011-012-0451-9
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1013467143</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2660411981</sourcerecordid><originalsourceid>FETCH-LOGICAL-c339t-e80777fc6d7c56e38f171e13ffe26371a929f811b2bb87f496282ca57baeb6363</originalsourceid><addsrcrecordid>eNp1kE1LAzEQhoMotlZ_gBdZ8BzNJNtNcpTiR6HQi4K3kE0Tu2W_TLJI_70pW8WLpxmYZ94ZHoSugdwBIfw-EEIAMAGKST4HLE_QFHJKsCTi_TT1hDLMBCMTdBHCLtGCCnqOJpQyTiQnU7ReNr2uvN1kxtZ15obWxKprQ9a5bGt7HTuzjzZkVWuGUsfEfVVxm_W1Do0-QMH2sTJZIivbxnCJzpyug7061hl6e3p8Xbzg1fp5uXhYYcOYjNgKwjl3pthwMy8sEw44WGDOWVowDlpS6QRASctScJfLIj1u9JyX2pYFK9gM3Y65ve8-Bxui2nWDb9NJBQRYXnDIWaJgpIzvQvDWqd5Xjfb7BKmDQjUqVEmhOihUMu3cHJOHsrGb340fZwmgIxDSqP2w_u_p_1K_Ackpe6A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1013467143</pqid></control><display><type>article</type><title>Impaired cell functions of hepatocytes incubated with plasma of septic patients</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Sauer, Martin ; Haubner, Cristof ; Mencke, Thomas ; Nöldge-Schomburg, Gabriele ; Mitzner, Steffen ; Altrichter, Jens ; Stange, Jan</creator><creatorcontrib>Sauer, Martin ; Haubner, Cristof ; Mencke, Thomas ; Nöldge-Schomburg, Gabriele ; Mitzner, Steffen ; Altrichter, Jens ; Stange, Jan</creatorcontrib><description>Objective and design The development of liver failure is a major problem in septic patients. In this prospective clinical experimental study the hepatotoxicity of plasma from septic and non-septic patients was tested. Methods and subjects The basic test components consist of human liver cells (HepG2/C3A) used in a standardized microtiter plate assay. After incubation with patient’s plasma viability of cells (XTT-test), the cytochrome 1A2 activity and synthesis of micro albumin were measured. Subjects (28) enrolled comprise the septic shock group (SSG, n  = 10), the non-septic group (NSG, n  = 5) and the healthy volunteers group (HVG, n  = 13). Results The 28-day mortality was 30% in the SSG. The APACHE II-, SOFA-, and SAPS-scores and the values of bilirubin and prothrombin time as INR were significantly higher in the SSG than in the NSG. The cytochrome 1A2 activity and the release of albumin were significantly reduced in HepG2/C3A cells incubated with plasma of the SSG ( p  &lt; 0.05). The cytochrome 1A2 activities were higher in survivors compared to non-survivors at the time point 0 and were increasing in survivors and decreasing in non-survivors within 54 h in the SSG. In the SSG there was a significant decrease in IL-10 and IL-8 between inclusion and 54 h. Values of IL-6, TNF alpha and IL-10 were significantly lower in the NSG compared with the values of the SSG at inclusion and after 54 h. Conclusion The plasma of patients with septic shock impaired cellular functions of HepG2/C3A cells.</description><identifier>ISSN: 1023-3830</identifier><identifier>EISSN: 1420-908X</identifier><identifier>DOI: 10.1007/s00011-012-0451-9</identifier><identifier>PMID: 22370970</identifier><language>eng</language><publisher>Basel: SP Birkhäuser Verlag Basel</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Albumins - metabolism ; Allergology ; Bilirubin - blood ; Biomedical and Life Sciences ; Biomedicine ; Case-Control Studies ; Cell Line, Tumor ; Cytochrome P-450 CYP1A2 - metabolism ; Cytokines - blood ; Dermatology ; Female ; Hepatocytes - metabolism ; Humans ; Immunology ; Liver Failure - blood ; Liver Failure - metabolism ; Male ; Middle Aged ; Neurology ; Original Research Paper ; Pharmacology/Toxicology ; Rheumatology ; Sepsis - blood ; Sepsis - metabolism</subject><ispartof>Inflammation research, 2012-06, Vol.61 (6), p.609-616</ispartof><rights>Springer Basel AG 2012</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c339t-e80777fc6d7c56e38f171e13ffe26371a929f811b2bb87f496282ca57baeb6363</citedby><cites>FETCH-LOGICAL-c339t-e80777fc6d7c56e38f171e13ffe26371a929f811b2bb87f496282ca57baeb6363</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00011-012-0451-9$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00011-012-0451-9$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27923,27924,41487,42556,51318</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22370970$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sauer, Martin</creatorcontrib><creatorcontrib>Haubner, Cristof</creatorcontrib><creatorcontrib>Mencke, Thomas</creatorcontrib><creatorcontrib>Nöldge-Schomburg, Gabriele</creatorcontrib><creatorcontrib>Mitzner, Steffen</creatorcontrib><creatorcontrib>Altrichter, Jens</creatorcontrib><creatorcontrib>Stange, Jan</creatorcontrib><title>Impaired cell functions of hepatocytes incubated with plasma of septic patients</title><title>Inflammation research</title><addtitle>Inflamm. Res</addtitle><addtitle>Inflamm Res</addtitle><description>Objective and design The development of liver failure is a major problem in septic patients. In this prospective clinical experimental study the hepatotoxicity of plasma from septic and non-septic patients was tested. Methods and subjects The basic test components consist of human liver cells (HepG2/C3A) used in a standardized microtiter plate assay. After incubation with patient’s plasma viability of cells (XTT-test), the cytochrome 1A2 activity and synthesis of micro albumin were measured. Subjects (28) enrolled comprise the septic shock group (SSG, n  = 10), the non-septic group (NSG, n  = 5) and the healthy volunteers group (HVG, n  = 13). Results The 28-day mortality was 30% in the SSG. The APACHE II-, SOFA-, and SAPS-scores and the values of bilirubin and prothrombin time as INR were significantly higher in the SSG than in the NSG. The cytochrome 1A2 activity and the release of albumin were significantly reduced in HepG2/C3A cells incubated with plasma of the SSG ( p  &lt; 0.05). The cytochrome 1A2 activities were higher in survivors compared to non-survivors at the time point 0 and were increasing in survivors and decreasing in non-survivors within 54 h in the SSG. In the SSG there was a significant decrease in IL-10 and IL-8 between inclusion and 54 h. Values of IL-6, TNF alpha and IL-10 were significantly lower in the NSG compared with the values of the SSG at inclusion and after 54 h. Conclusion The plasma of patients with septic shock impaired cellular functions of HepG2/C3A cells.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Albumins - metabolism</subject><subject>Allergology</subject><subject>Bilirubin - blood</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Case-Control Studies</subject><subject>Cell Line, Tumor</subject><subject>Cytochrome P-450 CYP1A2 - metabolism</subject><subject>Cytokines - blood</subject><subject>Dermatology</subject><subject>Female</subject><subject>Hepatocytes - metabolism</subject><subject>Humans</subject><subject>Immunology</subject><subject>Liver Failure - blood</subject><subject>Liver Failure - metabolism</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neurology</subject><subject>Original Research Paper</subject><subject>Pharmacology/Toxicology</subject><subject>Rheumatology</subject><subject>Sepsis - blood</subject><subject>Sepsis - metabolism</subject><issn>1023-3830</issn><issn>1420-908X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp1kE1LAzEQhoMotlZ_gBdZ8BzNJNtNcpTiR6HQi4K3kE0Tu2W_TLJI_70pW8WLpxmYZ94ZHoSugdwBIfw-EEIAMAGKST4HLE_QFHJKsCTi_TT1hDLMBCMTdBHCLtGCCnqOJpQyTiQnU7ReNr2uvN1kxtZ15obWxKprQ9a5bGt7HTuzjzZkVWuGUsfEfVVxm_W1Do0-QMH2sTJZIivbxnCJzpyug7061hl6e3p8Xbzg1fp5uXhYYcOYjNgKwjl3pthwMy8sEw44WGDOWVowDlpS6QRASctScJfLIj1u9JyX2pYFK9gM3Y65ve8-Bxui2nWDb9NJBQRYXnDIWaJgpIzvQvDWqd5Xjfb7BKmDQjUqVEmhOihUMu3cHJOHsrGb340fZwmgIxDSqP2w_u_p_1K_Ackpe6A</recordid><startdate>20120601</startdate><enddate>20120601</enddate><creator>Sauer, Martin</creator><creator>Haubner, Cristof</creator><creator>Mencke, Thomas</creator><creator>Nöldge-Schomburg, Gabriele</creator><creator>Mitzner, Steffen</creator><creator>Altrichter, Jens</creator><creator>Stange, Jan</creator><general>SP Birkhäuser Verlag Basel</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7T5</scope><scope>7T7</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20120601</creationdate><title>Impaired cell functions of hepatocytes incubated with plasma of septic patients</title><author>Sauer, Martin ; Haubner, Cristof ; Mencke, Thomas ; Nöldge-Schomburg, Gabriele ; Mitzner, Steffen ; Altrichter, Jens ; Stange, Jan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c339t-e80777fc6d7c56e38f171e13ffe26371a929f811b2bb87f496282ca57baeb6363</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Albumins - metabolism</topic><topic>Allergology</topic><topic>Bilirubin - blood</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Case-Control Studies</topic><topic>Cell Line, Tumor</topic><topic>Cytochrome P-450 CYP1A2 - metabolism</topic><topic>Cytokines - blood</topic><topic>Dermatology</topic><topic>Female</topic><topic>Hepatocytes - metabolism</topic><topic>Humans</topic><topic>Immunology</topic><topic>Liver Failure - blood</topic><topic>Liver Failure - metabolism</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neurology</topic><topic>Original Research Paper</topic><topic>Pharmacology/Toxicology</topic><topic>Rheumatology</topic><topic>Sepsis - blood</topic><topic>Sepsis - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sauer, Martin</creatorcontrib><creatorcontrib>Haubner, Cristof</creatorcontrib><creatorcontrib>Mencke, Thomas</creatorcontrib><creatorcontrib>Nöldge-Schomburg, Gabriele</creatorcontrib><creatorcontrib>Mitzner, Steffen</creatorcontrib><creatorcontrib>Altrichter, Jens</creatorcontrib><creatorcontrib>Stange, Jan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Inflammation research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sauer, Martin</au><au>Haubner, Cristof</au><au>Mencke, Thomas</au><au>Nöldge-Schomburg, Gabriele</au><au>Mitzner, Steffen</au><au>Altrichter, Jens</au><au>Stange, Jan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impaired cell functions of hepatocytes incubated with plasma of septic patients</atitle><jtitle>Inflammation research</jtitle><stitle>Inflamm. Res</stitle><addtitle>Inflamm Res</addtitle><date>2012-06-01</date><risdate>2012</risdate><volume>61</volume><issue>6</issue><spage>609</spage><epage>616</epage><pages>609-616</pages><issn>1023-3830</issn><eissn>1420-908X</eissn><abstract>Objective and design The development of liver failure is a major problem in septic patients. In this prospective clinical experimental study the hepatotoxicity of plasma from septic and non-septic patients was tested. Methods and subjects The basic test components consist of human liver cells (HepG2/C3A) used in a standardized microtiter plate assay. After incubation with patient’s plasma viability of cells (XTT-test), the cytochrome 1A2 activity and synthesis of micro albumin were measured. Subjects (28) enrolled comprise the septic shock group (SSG, n  = 10), the non-septic group (NSG, n  = 5) and the healthy volunteers group (HVG, n  = 13). Results The 28-day mortality was 30% in the SSG. The APACHE II-, SOFA-, and SAPS-scores and the values of bilirubin and prothrombin time as INR were significantly higher in the SSG than in the NSG. The cytochrome 1A2 activity and the release of albumin were significantly reduced in HepG2/C3A cells incubated with plasma of the SSG ( p  &lt; 0.05). The cytochrome 1A2 activities were higher in survivors compared to non-survivors at the time point 0 and were increasing in survivors and decreasing in non-survivors within 54 h in the SSG. In the SSG there was a significant decrease in IL-10 and IL-8 between inclusion and 54 h. Values of IL-6, TNF alpha and IL-10 were significantly lower in the NSG compared with the values of the SSG at inclusion and after 54 h. Conclusion The plasma of patients with septic shock impaired cellular functions of HepG2/C3A cells.</abstract><cop>Basel</cop><pub>SP Birkhäuser Verlag Basel</pub><pmid>22370970</pmid><doi>10.1007/s00011-012-0451-9</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1023-3830
ispartof Inflammation research, 2012-06, Vol.61 (6), p.609-616
issn 1023-3830
1420-908X
language eng
recordid cdi_proquest_journals_1013467143
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Adult
Aged
Aged, 80 and over
Albumins - metabolism
Allergology
Bilirubin - blood
Biomedical and Life Sciences
Biomedicine
Case-Control Studies
Cell Line, Tumor
Cytochrome P-450 CYP1A2 - metabolism
Cytokines - blood
Dermatology
Female
Hepatocytes - metabolism
Humans
Immunology
Liver Failure - blood
Liver Failure - metabolism
Male
Middle Aged
Neurology
Original Research Paper
Pharmacology/Toxicology
Rheumatology
Sepsis - blood
Sepsis - metabolism
title Impaired cell functions of hepatocytes incubated with plasma of septic patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T11%3A18%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impaired%20cell%20functions%20of%20hepatocytes%20incubated%20with%20plasma%20of%20septic%20patients&rft.jtitle=Inflammation%20research&rft.au=Sauer,%20Martin&rft.date=2012-06-01&rft.volume=61&rft.issue=6&rft.spage=609&rft.epage=616&rft.pages=609-616&rft.issn=1023-3830&rft.eissn=1420-908X&rft_id=info:doi/10.1007/s00011-012-0451-9&rft_dat=%3Cproquest_cross%3E2660411981%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1013467143&rft_id=info:pmid/22370970&rfr_iscdi=true